Michael Wasserman
Consultant / Advisor chez H.I.G. BioHealth Partners LLC
Profil
Michael is an Operating Partner at Maverix.? ?
Prior to joining Maverix, Michael spent 17 years at H.I.G.
Capital Management,?a leading global private equity investment firm with more than $44?billion?of equity capital under management.
Most recently, Michael?was?a Managing?Director of H.I.G.
BioHealth Partners, the firm's dedicated healthcare investment fund, where Michael?sourced, executed and managed a diverse investment portfolio of healthcare business across stages, sectors and geographies, including?HyperBranch? Medical (acquired: Stryker Corporation),?NeuWave?Medical (acquired: Johnson & Johnson) and?VertiFlex?Medical (acquired: Boston Scientific) and others.
Michael has also founded and held senior operating roles in several disruptive private equity and venture capital-backed businesses.
Earlier in his career, Michael worked directly for, or as a consultant to, emerging technology companies, and in the corporate finance, pharmaceutical and clinical research industries.
Michael received his B.Sc.
from McGill University and his Ph.D.
in Pharmacology and Neuroscience from the University of Toronto.
Michael serves on the Board of Trustees for the Holland Bloorview Kids Rehabilitation Hospital, where he is on the Business and Audit Committee and Chairs the Investment Subcommittee.
Michael is also a member of the Board of Directors for Toronto Innovation Acceleration Partners (TIAP), where he chairs the Investment Committee, is on the Board of ORT Canada and serves on the Faculty of Science Advisory Board at McGill University.
Postes actifs de Michael Wasserman
| Sociétés | Poste | Début |
|---|---|---|
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Consultant / Advisor | 01/05/2021 |
Anciens postes connus de Michael Wasserman
| Sociétés | Poste | Fin |
|---|---|---|
Maverix Private Equity
 Maverix Private Equity Investment ManagersFinance Maverix Private Equity (Maverix Private Equity) is a venture capital firm founded in 2019 by John Ruffolo and Mark G. Maybank. The firm is headquartered in Toronto, Canada. | Private Equity Investor | 01/01/2024 |
Vertiflex, Inc.
 Vertiflex, Inc. Medical SpecialtiesHealth Technology VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA. | Directeur/Membre du Conseil | 18/06/2019 |
| CELLutions Biosystems, Inc. | Fondateur | 01/01/2004 |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Directeur/Membre du Conseil | - |
NeuWave Medical, Inc.
 NeuWave Medical, Inc. Medical SpecialtiesHealth Technology NeuWave Medical, Inc. develops soft tissue ablation systems. Its products include 140 microwave ablation system which is used in surgeries. The company was founded by Fred T. Lee, Jr., Daniel van der Weid, Christopher Brace, and Paul F. Laeseke in 2004 and is headquartered in Madison, WI. | Directeur/Membre du Conseil | - |
Formation de Michael Wasserman
| University of Toronto | Doctorate Degree |
| McGill University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
HyperBranch Medical Technology, Inc.
 HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Health Technology |
| CELLutions Biosystems, Inc. | |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Finance |
Advanced Therapeutics of Wisconsin, Inc.
 Advanced Therapeutics of Wisconsin, Inc. Finance/Rental/LeasingFinance Advanced Therapeutics of Wisconsin, Inc. provides hospital beds and related equipment leasing services. The company is headquartered in Muskego, WI. | Finance |
NeuWave Medical, Inc.
NeuWave Medical, Inc. Medical SpecialtiesHealth Technology NeuWave Medical, Inc. develops soft tissue ablation systems. Its products include 140 microwave ablation system which is used in surgeries. The company was founded by Fred T. Lee, Jr., Daniel van der Weid, Christopher Brace, and Paul F. Laeseke in 2004 and is headquartered in Madison, WI. | Health Technology |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Health Technology |
Vertiflex, Inc.
Vertiflex, Inc. Medical SpecialtiesHealth Technology VertiFlex, Inc. operates as a medical device company. It offers minimally invasive solutions for the treatment of lumbar spinal stenosis (LSS), which is the cause of spinal surgery in the elderly. The firm specializes in minimally invasive, motion preservation, spine and medical device. The company was founded by Moti Altarac in 2005 and is headquartered in San Clemente, CA. | Health Technology |
Maverix Private Equity
Maverix Private Equity Investment ManagersFinance Maverix Private Equity (Maverix Private Equity) is a venture capital firm founded in 2019 by John Ruffolo and Mark G. Maybank. The firm is headquartered in Toronto, Canada. | Finance |
